F15.229: Other stimulant dependence with intoxication, unspecified
F15.229 is a billable, specific ICD-10-CM code for other stimulant dependence with intoxication, unspecified. It is valid for submission on a claim.
Check F15.229 with the rest of the claim: free scrubberInclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Amphetamine or other stimulant use disorder, moderate, with amphetamine or other stimulant intoxication, without perceptual disturbances
- Amphetamine or other stimulant use disorder, severe, with amphetamine or other stimulant intoxication, without perceptual disturbances
Excludes1 inherited from the categories above F15.229
A category’s note binds every code beneath it.
Excludes2 inherited from the categories above F15.229
Not part of this code, but both may be coded when both are present.
Risk adjustment
F15.229 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 137 Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications0.424 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
F15.229 is named in 14 Medicare coverage policies: 11 listing it as supporting medical necessity, and 3 listing it as NOT covered. Which one applies depends on your Medicare contractor.
- A52434Health and Behavior Assessment/Intervention – Medical Policy Articlenot covered
- A56562Billing and Coding: Health and Behavior Assessment/Interventionnot covered
- A59718Billing and Coding: Opioid Treatment Programsnot covered
- A56614Billing and Coding: Psychiatric Inpatient Hospitalization
Alphabetic index entries that lead here
- Dependence›drug NEC›stimulant NEC›with›intoxication
- Disorder›amphetamine use›moderate or severe›with›amphetamine, cocaine, or other stimulant intoxication›without perceptual disturbances
Code history
Unchanged in every release from FY2024 to FY2027.